Depression can lead to poor outcomes during antiretroviral therapy, and current evidence suggests high rates of depression among people living with human immunodeficiency virus (PLHIV), especially in low-and middle-income countries.
Off-the-shelf and on the decline: Adicet Bio’s shares halved after PhI look at cell therapy
Adicet Bio’s stock price was halved on Tuesday morning as investors tanked the biotech’s shares $ACET following a look at Phase I data on its
June 28, 2023